CINECA IRIS Institutional Research Information System

MAINA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17936
EU - Europa 16228
AS - Asia 5918
SA - Sud America 518
OC - Oceania 275
AF - Africa 110
Continente sconosciuto - Info sul continente non disponibili 61
Totale 41046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17364
IT - Italia 5271
CN - Cina 3356
IE - Irlanda 1904
FR - Francia 1498
DE - Germania 1304
SE - Svezia 1140
UA - Ucraina 1095
KR - Corea 963
FI - Finlandia 900
GB - Regno Unito 858
PL - Polonia 594
CA - Canada 446
VN - Vietnam 403
ES - Italia 343
JP - Giappone 276
NL - Olanda 246
BR - Brasile 244
AU - Australia 237
IN - India 217
TR - Turchia 196
BE - Belgio 185
RU - Federazione Russa 184
TW - Taiwan 113
CH - Svizzera 109
MX - Messico 95
PT - Portogallo 92
RO - Romania 91
AT - Austria 83
GR - Grecia 81
DK - Danimarca 80
CL - Cile 72
HK - Hong Kong 69
CO - Colombia 67
ID - Indonesia 59
EU - Europa 58
AR - Argentina 57
SG - Singapore 46
IL - Israele 38
NZ - Nuova Zelanda 38
NO - Norvegia 37
EC - Ecuador 36
PE - Perù 32
IR - Iran 31
TH - Thailandia 28
ZA - Sudafrica 23
EG - Egitto 22
RS - Serbia 22
HR - Croazia 16
LT - Lituania 16
LK - Sri Lanka 15
MY - Malesia 15
PK - Pakistan 15
TN - Tunisia 15
CR - Costa Rica 13
CZ - Repubblica Ceca 12
HU - Ungheria 12
IS - Islanda 12
SA - Arabia Saudita 12
SI - Slovenia 12
PH - Filippine 11
MA - Marocco 9
BG - Bulgaria 8
IQ - Iraq 8
LB - Libano 7
KE - Kenya 6
NG - Nigeria 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
AL - Albania 5
MO - Macao, regione amministrativa speciale della Cina 5
MU - Mauritius 5
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
JO - Giordania 4
PR - Porto Rico 4
BD - Bangladesh 3
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
QA - Qatar 3
SN - Senegal 3
UZ - Uzbekistan 3
VE - Venezuela 3
A1 - ???statistics.table.value.countryCode.A1??? 2
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CU - Cuba 2
KG - Kirghizistan 2
LY - Libia 2
PA - Panama 2
PS - Palestinian Territory 2
RE - Reunion 2
SC - Seychelles 2
SD - Sudan 2
SR - Suriname 2
SY - Repubblica araba siriana 2
Totale 41023
Salva come PNG Salva come JPEG
Città #
Beijing 2447
Houston 2225
Chandler 2187
Dublin 1884
Villeurbanne 896
Jacksonville 885
Fairfield 860
Medford 649
Ann Arbor 603
Princeton 603
Wilmington 545
Redwood City 542
Woodbridge 528
Torino 522
Warsaw 490
Ashburn 438
Nyköping 385
Seattle 363
Milan 350
Cambridge 312
Dearborn 306
Pisa 254
Boston 240
Dong Ket 199
Rome 154
Boardman 131
Turin 131
Toronto 117
Brussels 108
Verona 106
Nanjing 97
Norwalk 96
Taipei 91
Ottawa 89
Des Moines 82
Tokyo 81
Shanghai 78
Hefei 67
London 63
Guangzhou 62
Piemonte 61
Fremont 58
San Diego 56
Hangzhou 55
Falls Church 53
Vienna 49
Santiago 48
Florence 46
Bologna 44
Philadelphia 43
Amsterdam 42
Lachine 41
Central District 38
Kunming 38
São Paulo 38
Istanbul 37
New York 37
Jinan 36
Madrid 36
Chengdu 35
Seoul 35
Padova 34
Sudbury 32
Sydney 32
Wuhan 32
Nanchang 31
Paris 31
Zhengzhou 31
Palermo 30
Jakarta 29
Barcelona 28
Dallas 27
Raritan 27
Mountain View 26
Phoenix 26
Bari 25
San Mateo 25
Changsha 24
Genova 24
Melbourne 23
Perugia 23
Aarhus 22
Brescia 21
Silver Spring 21
Trieste 21
Düsseldorf 20
Medellín 20
Serra 20
Shenyang 20
Chicago 19
Duncan 19
Perth 19
Rochester 19
Singapore 19
Ankara 18
Bengaluru 18
Berlin 18
Buenos Aires 18
Catania 18
Central 18
Totale 22120
Salva come PNG Salva come JPEG
Nome #
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder. 2087
Trattamento con litio e potenziali effetti collaterali a lungo termine: una revisione sistematica della letteratura 1202
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 773
Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. 675
Lithium prophylaxis during pregnancy and the postpartum period in women with lithium-responsive bipolar I disorder 557
Paliperidone palmitate and metabolic syndrome in patients with schizophrenia a 12-month observational prospective cohort study 501
Involuntary admissions in Italy: the impact of seasonality 415
Gender-related distribution of personality disorders in a sample of patients with panic disorder. 408
Lithium-associated hyperparathyroidism and hypercalcaemia: A case-control cross-sectional study 372
Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women. 364
Affective recurrences in bipolar disorder after switching from lithium to valproate or vice versa: A series of 57 cases 344
Increased uric acid levels in bipolar disorder subjects during different phases of illness. 333
Glucose metabolism alterations in patients with bipolar disorder. 311
A randomized, single-blind comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression 303
Stressful life events and obsessive-compulsive disorder: clinical features and symptom dimensions 299
Il temperamento ciclotimico nei pazienti con DOC. 277
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 268
Combining drug and psychological treatments for obsessive-compulsive disorder: What is the evidence, when and for whom 268
Metabolic syndrome and Obsessive-Compulsive Disorder: a naturalistic Italian study 262
Anticorpi anti-SNC in adulti con disturbo ossessivo-compulsivo 260
Sindrome metabolica e disturbi psichiatrici: confronto tra disturbo bipolare e disturbo ossessivo-compulsivo 260
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain. 260
High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder 258
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 256
Onset of obsessive-compulsive disorder: premorbid conditions and prodromal phase 248
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder 246
Anti-brain antibodies in adult patients with obsessive-compulsive disorder 245
Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. 242
General Medical Conditions Are Associated With Delay to Treatment in Patients with Bipolar Disorder. 237
Duloxetina e bupropione in pazienti con disturbo depressivo maggiore resistente agli SSRI 219
Brief dynamic therapy and depression severity: a single-blind, randomized study. 218
Obsessive-compulsive disorder and cyclothymic temperament: an exploration of clinical features 214
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: A case-control study 212
Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study 210
The role of the potassium channel gene KCNK2 in major depressive disorder 208
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 193
No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression 192
Mania mista e antidepressivi: uno studio clinico su un campione di pazienti ricoverati per disturbo bipolare 190
Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates 188
Cyclothymic temperament and major depressive disorder: A study on Italian patients 187
Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: Long-term results 184
The use of antidepressants in bipolar disorder 181
Il disturbo ossessivo-compulsivo di personalità (DOCP): prevalenza nei pazienti con disturbi d'ansia e nei soggetti sani 177
Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study. 171
Terapia farmacologica della distimia: uno studio di confronto fra amisulpride, fluoxetina e lorazepam 158
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. 149
Efficacia e tollerabilità della Lofepramina nel trattamento della depressione nel paziente ambulatoriale 147
Differenze di genere nel disturbo ossessivo-compulsivo: uno studio clinico su 415 pazienti. 143
Bipolar disorders: is there an influence of seasonality or photoperiod? 142
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 139
L’inquadramento nosografico dei disturbi dell’umore: dai sintomi alla diagnosi, dalla diagnosi alla terapia. 137
Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study. 137
L’intervento psicoeducazionale multifamiliare (IPM) nel disturbo ossessivo-compulsivo: uno studio pilota 136
Paziente ricoverato per episodio maniacale : trattamento con asenapina in acuto e nel lungo termine 136
Disturbo ossessivo-compulsivo sottosoglia 135
Combined treatments in obsessive-compulsive disorder: current knowledge and future prospects. 134
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy. 134
Disturbo ossessivo-compulsivo con concomitanti disturbi da uso di sostanze: uno studio clinico 133
Can quetiapine extended release (ER) induce labial edema in a female patient with treatment-resistant major depressive episode? 133
Disturbi bipolari e d’ansia: aspetti epidemiologici e clinici. 127
Gender related differences in the onset of panic disorder 124
C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants used in major depressive disorder in the regional Italian settings of Veneto and Sardinia. 123
The Impact of General Medical Conditions in Obsessive-Compulsive Disorder 121
Cleptomania associata a terapia con dopaminoagonista in un paziente affetto da malattia di Parkinson 120
Episodic and chronic obsessive-compulsive disorder. 119
L’intervento psicoeducazionale multifamiliare nel disturbo ossessivo-compulsivo 118
Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire. 118
Il disturbo ossessivo-compulsivo. Epidemiologia e clinica. 116
Tecniche di stimolazione cerebrale nel trattamento della depressione resistente [Brain stimulation therapies for treatment-resistant depression]. 116
Diagnostic delay in ADHD: Duration of untreated illness and its socio-demographic and clinical predictors in a sample of adult outpatients 116
Early childhood infections, antistreptococcal and basal ganglia antibodies in adult ADHD: a preliminary study 115
Common and specific blood microRNA alterations in unipolar and bipolar depression 114
Correlates of violent suicide attempts in patients with bipolar disorder 110
Hoarding e disturbo ossessivo-compulsivo (DOC): due entità cliniche distinte in comorbilità o hoarding secondario al DOC? 107
Lithium and anticonvulsants in the treatment of mania and in the prophylaxis of recurrences 105
Impact of comorbid obsessive-compulsive disorder on suicidality in patients with bipolar disorder 105
Fenomenologia del paziente con disturbo ossessivo-compulsivo ad esordio precoce e ad esordio in età adulta 103
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder 101
Definizione e strategie terapeutiche della depressione resistente al trattamento: una revisione della letteratura 99
Effectiveness of cognitive-behavioural therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study. 99
Studio clinico sperimentale spontaneo sul trattamento della depressione maggiore resistente mediante stimolezione del nervo vago: risultati a due anni di follow-up 98
Trattamento farmacologico con sali di litio in pazienti affetti da disturbo bipolare: cosa succede al metabolismo del calcio? 98
A 10-year evaluation on adolescents with anxiety disorders: are they at risk of bipolarity? 97
[Generalized anxiety disorder. Clinical and nosological remarks] 96
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia. 95
L’influenza della comorbidità con disturbo bipolare sulla clinica del disturbo ossessivo-compulsivo 95
Validità ed affidabilità del Quality of Life, Enjoyment and Satisfaction Questionnaire, versione breve 95
La stimolazione del nervo vago (VNS) nel trattamento della depressione maggiore resistente: risultati preliminari di uno studio clinico sperimentale spontaneo 95
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 93
Ansia e disturbo bipolare: comorbilità o epifenomeno? 92
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context 91
La comorbidità del disturbo ossessivo-compulsivo con i disturbi di asse I: differenza tra i sessi e correlazione con il decorso clinico 90
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 90
Il disturbo ossessivo compulsivo 89
[The general practitioner and psychiatric assistance. A study carried out in the Piedmont region] 88
Il trattamento farmacologico della distimia: uno studio clinico. 87
Brief dynamic therapy combined with pharmacotherapy in the treatment of panic disorder with concurrent depressive symptoms. 87
Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness 87
Serum BDNF in OCD and major depressive disorder patients before and during antidepressant treatment. European neuropsychopharmacology 2010, 20 (3): S541-S541. 86
Adjunctive fluoxetine or amisulpride improves schizophrenic negative symptoms. 86
Totale 21779
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71462
article - articoli 0
book - libri 0
conference - conferenze 18873
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90335
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018317 0000 00 00 000317
2018/20194302 260206353260 237395 182474 207415980333
2019/20207419 330363529738 5291647 756512 758420460377
2020/20216052 583299560345 502432 746299 673489456668
2021/20225262 307252326303 326255 364378 3482767121415
2022/20238254 891545335730 7022143 818571 7562545081
Totale 42789